1. Home
  2. ACHV vs GF Comparison

ACHV vs GF Comparison

Compare ACHV & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • GF
  • Stock Information
  • Founded
  • ACHV N/A
  • GF 1990
  • Country
  • ACHV Canada
  • GF Germany
  • Employees
  • ACHV N/A
  • GF N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GF Investment Managers
  • Sector
  • ACHV Health Care
  • GF Finance
  • Exchange
  • ACHV Nasdaq
  • GF Nasdaq
  • Market Cap
  • ACHV 137.6M
  • GF 138.1M
  • IPO Year
  • ACHV N/A
  • GF N/A
  • Fundamental
  • Price
  • ACHV $3.69
  • GF $7.93
  • Analyst Decision
  • ACHV Strong Buy
  • GF
  • Analyst Count
  • ACHV 5
  • GF 0
  • Target Price
  • ACHV $14.80
  • GF N/A
  • AVG Volume (30 Days)
  • ACHV 142.3K
  • GF 28.1K
  • Earning Date
  • ACHV 11-07-2024
  • GF 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • GF 0.82%
  • EPS Growth
  • ACHV N/A
  • GF N/A
  • EPS
  • ACHV N/A
  • GF N/A
  • Revenue
  • ACHV N/A
  • GF N/A
  • Revenue This Year
  • ACHV N/A
  • GF N/A
  • Revenue Next Year
  • ACHV N/A
  • GF N/A
  • P/E Ratio
  • ACHV N/A
  • GF N/A
  • Revenue Growth
  • ACHV N/A
  • GF N/A
  • 52 Week Low
  • ACHV $3.41
  • GF $7.38
  • 52 Week High
  • ACHV $5.59
  • GF $9.41
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 26.02
  • GF 32.28
  • Support Level
  • ACHV $4.07
  • GF $8.09
  • Resistance Level
  • ACHV $4.21
  • GF $8.44
  • Average True Range (ATR)
  • ACHV 0.22
  • GF 0.10
  • MACD
  • ACHV -0.06
  • GF -0.03
  • Stochastic Oscillator
  • ACHV 8.49
  • GF 7.80

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

Share on Social Networks: